Aging is the major risk factor for most human diseases and affects every single individual in the world. The development of novel strategies to extend human healthspan and lifespan is currently a rapidly growing area of research and might represent one of the best investment opportunities from a philanthropic and business perspective.

Our achivements


Research articles and reviews




Swiss Francs (CHF) in funding

Public funding sources

Swiss National Science Foundation

Logo Novartis

Novartis Foundation for Medical-Biological Research

Canton de Vaud

Canton de Vaud

Fundation Pierre Mercer pour la Science

Fondation Pierre Mercier pour la Science

Université de Lausanne

Collaborations with industry

Coming soon…

Get involved


You can now participate in accelerating the development of the next generation of anti-aging therapies by supporting some of our research projects.